FDA Clearance Tracker · P870072
THORATEC(R) VENTRICULAR ASSIST DEVICE (VAD) SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 20, 1995 (this decision)Source: openFDAMethods & limitations
Decided
Dec 20, 1995
Approval withdrawn
Time to decision
2,948 days
Received Nov 24, 1987. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P870072
- Device name
- THORATEC(R) VENTRICULAR ASSIST DEVICE (VAD) SYSTEM
- Applicant
- Thoratec Laboratories Corp.
- Applicant location
- Berkeley, CA
- Received
- Nov 24, 1987
- Decided
- Dec 20, 1995
- Decision
- Approval withdrawn
- Supplements
- 58 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
INTENDED AS A BRIDGE TO CARDIAC TRANSPLANTATION FOR USE IN PATIENTS SUFFERING FROM END-STAGE HEART FAILURE. THE PATIENT SHOULD MEET ALL OF THE FOLLOWING CRITERIA: 1)CANDIDATE FOR CARDIAC TRANSPLANTATION, 2) IMMINENT RISK OF DYING BEFORE DONOR HEART PROCUREMENT, AND 3) DEPENDENCE O N, OR INCOMPLETE RESPONSE TO, CONTINUE VASOPRESSOR SUPPORT
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DSQ. The earliest in FDA's data is P900023, decided Nov 20, 1992.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Thoratec Laboratories Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.